Science Explorer Back to mapMap
Discussion
Researcher · Bone Therapeutics · Belgium

Shruthi Prasad

Shruthi Prasad publishes mostly in Oncology, Immunology and Biomedical Engineering, on topics such as Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and CAR-T cell therapy research.

ORCID 0000-0003-1787-548X OpenAlex
World rank
#1,332,512
of 7,710,434 ranked researchers
Rank in Belgium
#12,251
of 67,186
Works
58
Citations
530
Citations per work
9.1
h-index
7
i10-index 6Top 78% in Oncology
Shruthi Prasad

What does Shruthi Prasad research?

Shruthi Prasad's work is mostly in Medicine (36%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (13%).

Life Sciences: 22 works · 37.8% of their workImmunology and Microbiology: 14 works · 24.4% of their workImmunology: 14 works · 24.4% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 13.4% of their workBiotechnology: 4 works · 6.7% of their workPhysiology: 4 works · 6.7% of their workHealth Sciences: 21 works · 35.5% of their workMedicine: 21 works · 35.5% of their workOncology: 18 works · 31.1% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 4.4% of their workEverything else: 9 works · 15.6% of their workPhysical Sciences: 6 works · 11.1% of their workEngineering: 6 works · 11.1% of their workBiomedical Engineering: 6 works · 11.1% of their workTHEIR WORKShruthi Prasad58works
Life Sciences38%Physical Sciences11%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1424.4%
    2. Biochemistry, Genetics and Molecular Biology813.4%
    1. Medicine2135.5%
  3. Everything else915.6%
    1. Engineering611.1%
  1. 1Oncology31% of their works
  2. 2Immunology24% of their works
  3. 3Biomedical Engineering11% of their works
  4. 4Biotechnology7% of their works
  5. 5Physiology7% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Shruthi Prasad's research?

The keywords of their largest research topics: Immunotherapy, Cancer Immunotherapy, Tumor Microenvironment, Tumor Regression, Immune Checkpoint Blockade, PD-1 and PD-L1, Tumor Targeting and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Immunotherapy113 topics
  2. Cancer Immunotherapy102 topics
  3. Tumor Microenvironment92 topics
  4. Tumor Regression82 topics
  5. Immune Checkpoint Blockade61 topic
  6. PD-1 and PD-L161 topic
  7. Tumor Targeting62 topics
  8. CAR T Cells51 topic
  9. Chimeric Antigen Receptor51 topic
  10. Dendritic Cells51 topic
  11. Immunity51 topic
  12. NK Cell Recognition41 topic
  13. Natural Killer Cells41 topic
  14. Adenosine Receptors31 topic
  15. Arginine Deprivation31 topic
  16. Bacterial Therapy31 topic
  17. Cancer Stem Cells31 topic
  18. Nanoparticles31 topic
  19. Photothermal Therapy31 topic
  20. Purinergic Signalling31 topic
  21. Tumor Metastasis31 topic

Where does Shruthi Prasad work?

Shruthi Prasad's main affiliation in the publication record is Bone Therapeutics, Belgium.

How many publications and citations does Shruthi Prasad have?

OpenAlex counts 58 works and 530 citations for Shruthi Prasad, an h-index of 7, ranking #1,332,512 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shruthi Prasad. Posts are plain text and can be reported.